207 related articles for article (PubMed ID: 7411555)
21. Benzo[a]carbazole derivatives. Synthesis, estrogen receptor binding affinities, and mammary tumor inhibiting activity.
von Angerer E; Prekajac J
J Med Chem; 1986 Mar; 29(3):380-6. PubMed ID: 3950918
[TBL] [Abstract][Full Text] [Related]
22. Methodology for the synthesis and specific activity determination of 16 alpha-[77Br]-bromoestradiol-17 beta and 16 alpha-[77Br]-11 beta-methoxyestradiol-17 beta, two estrogen receptor-binding radiopharmaceuticals.
Senderoff SG; McElvany KD; Carlson KE; Heiman DF; Katzenellenbogen JA; Welch MJ
Int J Appl Radiat Isot; 1982 Jul; 33(7):545-51. PubMed ID: 6889575
[TBL] [Abstract][Full Text] [Related]
23. In vivo comparison of 16 alpha[77Br]bromoestradiol-17 beta and 16 alpha-[125I]iodoestradiol-17 beta.
McElvany KD; Carlson KE; Welch MJ; Senderoff SG; Katzenellenbogen JA
J Nucl Med; 1982 May; 23(5):420-4. PubMed ID: 7077396
[TBL] [Abstract][Full Text] [Related]
24. Oxohexestrol derivatives labeled with fluorine-18. Synthesis, receptor binding and in vivo distribution of two non-steroidal estrogens as potential breast tumor imaging agents.
Bergmann KE; Landvatter SW; Rocque PG; Carlson KE; Welch MJ; Katzenellenbogen JA
Nucl Med Biol; 1994 Jan; 21(1):25-39. PubMed ID: 9234261
[TBL] [Abstract][Full Text] [Related]
25. Iodoestrogens, syntheses, and interaction with uterine receptors.
Arunachalam T; Longcope C; Caspi E
J Biol Chem; 1979 Jul; 254(13):5900-5. PubMed ID: 447687
[TBL] [Abstract][Full Text] [Related]
26. Factors affecting the target site uptake selectivity of estrogen radiopharmaceuticals: serum binding and endogenous estrogens.
McElvany KD; Carlson KE; Katzenellenbogen JA; Welch MJ
J Steroid Biochem; 1983 Jun; 18(6):635-41. PubMed ID: 6191127
[TBL] [Abstract][Full Text] [Related]
27. Estrogen receptor binding affinity and uterotrophic activity of triphenylhaloethylenes.
DeSombre ER; Mease RC; Sanghavi J; Singh T; Seevers RH; Hughes A
J Steroid Biochem; 1988 Jun; 29(6):583-90. PubMed ID: 3386226
[TBL] [Abstract][Full Text] [Related]
28. 16 alpha-[77Br]bromo-11 beta-methoxyestradiol-17 beta: a gamma-emitting estrogen imaging agent with high uptake and retention by target organs.
Katzenellenbogen JA; McElvany KD; Senderoff SG; Carlson KE; Landvatter SW; Welch MJ
J Nucl Med; 1982 May; 23(5):411-9. PubMed ID: 7077395
[TBL] [Abstract][Full Text] [Related]
29. Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships.
Connor K; Ramamoorthy K; Moore M; Mustain M; Chen I; Safe S; Zacharewski T; Gillesby B; Joyeux A; Balaguer P
Toxicol Appl Pharmacol; 1997 Jul; 145(1):111-23. PubMed ID: 9221830
[TBL] [Abstract][Full Text] [Related]
30. Bisphenol a binds to the low-affinity estrogen binding site.
Washington W; Hubert L; Jones D; Gray WG
In Vitr Mol Toxicol; 2001; 14(1):43-51. PubMed ID: 11689155
[TBL] [Abstract][Full Text] [Related]
31. Flavonoids. 8. Synthesis and antifertility and estrogen receptor binding activities of coumarins and delta3-isoflavenes.
Wani MC; Rector DH; Christensen HD; Kimmel GL; Cook CE
J Med Chem; 1975 Oct; 18(10):982-5. PubMed ID: 169352
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, estrogen receptor binding, and tissue distribution of [18F]fluorodoisynolic acids.
Scribner AW; Jonson SD; Welch MJ; Katzenellenbogen JA
Nucl Med Biol; 1997 Apr; 24(3):209-24. PubMed ID: 9228655
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and receptor binding of polynuclear organometallic estradiol derivatives.
Vessieres A; Jaouen G; Gruselle M; Rossignol JL; Savignac M; Top S; Greenfield S
J Steroid Biochem; 1988; 30(1-6):301-6. PubMed ID: 3386257
[TBL] [Abstract][Full Text] [Related]
34. 2-(Hydroxyalkyl)estradiols: synthesis and biological evaluation.
Lovely CJ; Gilbert NE; Liberto MM; Sharp DW; Lin YC; Brueggemeier RW
J Med Chem; 1996 Apr; 39(9):1917-23. PubMed ID: 8627615
[TBL] [Abstract][Full Text] [Related]
35. Biological activities of 4-fluoro estrogen analogues.
Longcope C; Rafkind I; Arunachalam T; Caspi E
J Steroid Biochem; 1983 Sep; 19(3):1325-8. PubMed ID: 6621038
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of A-ring fluorinated derivatives of (17 alpha,20E/Z)-[125I]iodovinylestradiols: effect on receptor binding and receptor-mediated target tissue uptake.
Ali H; Rousseau J; van Lier JE
J Med Chem; 1993 Oct; 36(21):3061-72. PubMed ID: 8230092
[TBL] [Abstract][Full Text] [Related]
37. Selenium labeling in nuclear medicine. 2. D ring substituted estrogens.
Sadek SA; Kessler WV; Shaw SM; Anderson JN; Wolf GC
J Med Chem; 1982 Dec; 25(12):1488-92. PubMed ID: 6891404
[No Abstract] [Full Text] [Related]
38. Ring-substituted 1,2-dialkylated 1,2-bis(hydroxyphenyl)ethanes. 3. Synthesis, estrogen receptor binding affinity, and evaluation of antiestrogenic and mammary tumor inhibiting activity of 2,2'-disubstituted butestrols and 6,6'-disubstituted metabutestrols.
Hartmann RW; Heindl A; Schwarz W; Schönenberger H
J Med Chem; 1984 Jul; 27(7):819-24. PubMed ID: 6330356
[TBL] [Abstract][Full Text] [Related]
39. Bromine-80m-labeled estrogens: Auger electron-emitting, estrogen receptor-directed ligands with potential for therapy of estrogen receptor-positive cancers.
DeSombre ER; Mease RC; Hughes A; Harper PV; DeJesus OT; Friedman AM
Cancer Res; 1988 Feb; 48(4):899-906. PubMed ID: 3338083
[TBL] [Abstract][Full Text] [Related]
40. 11 beta-chloromethyl-[3H]estradiol-17 beta: a very high affinity, reversible ligand for the estrogen receptor.
Bindal RD; Carlson KE; Reiner GC; Katzenellenbogen JA
J Steroid Biochem; 1987 Oct; 28(4):361-70. PubMed ID: 3669657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
